Deletion of Hyaluronan Synthase 3 Inhibits Neointimal Hyperplasia in Mice
Author(s) -
Lena S. Kiene,
Susanne Homann,
Tatsiana Suvorava,
Berit Rabausch,
Julia Müller,
Georg Kojda,
Inga Kretschmer,
Sören Twarock,
Guang Dai,
René Deenen,
Sonja Hartwig,
Stefan Lehr,
Karl Köhrer,
Rashmin C. Savani,
Maria Grandoch,
Jens W. Fischer
Publication year - 2016
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.115.306607
Subject(s) - hyaluronan synthase , neointimal hyperplasia , pericyte , neointima , extracellular matrix , chemistry , microbiology and biotechnology , vascular smooth muscle , endothelial stem cell , biology , endocrinology , medicine , biochemistry , in vitro , restenosis , stent , smooth muscle
Hyaluronan (HA) is a polymeric glucosaminoglycan that forms a provisional extracellular matrix in diseased vessels. HA is synthesized by 3 different HA synthases (HAS1, HAS2, and HAS3). Aim of this study was to unravel the role of the HAS3 isoenzyme during experimental neointimal hyperplasia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom